Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Schuster

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Molecular Diagnostics : JMD|March 23, 2010
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylationPhilipp Schatz, Dimo Dietrich, Thomas Koenig, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 10, 2022
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growthKarthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, et al.
Clinical Chemistry|December 20, 2007
DNA methylation biomarkers for blood-based colorectal cancer screeningCatherine Lofton-Day, Fabian Model, Theo Devos, et al.
Clinical Chemistry|May 2, 2009
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancerTheo deVos, Reimo Tetzner, Fabian Model, et al.
Nature Communications|January 20, 2022
Crystal structure of the α<sub>1B</sub>-adrenergic receptor reveals molecular determinants of selective ligand recognitionMattia Deluigi, Lena Morstein, Matthias Schuster, et al.
Science Advances|May 24, 2023
Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant EnterobacteriaceaeMatthias Schuster, Emile Brabet, Kathryn K Oi, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Molecular Diagnostics : JMD|March 23, 2010
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylationPhilipp Schatz, Dimo Dietrich, Thomas Koenig, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 10, 2022
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growthKarthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, et al.
Clinical Chemistry|December 20, 2007
DNA methylation biomarkers for blood-based colorectal cancer screeningCatherine Lofton-Day, Fabian Model, Theo Devos, et al.
Clinical Chemistry|May 2, 2009
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancerTheo deVos, Reimo Tetzner, Fabian Model, et al.
Nature Communications|January 20, 2022
Crystal structure of the α<sub>1B</sub>-adrenergic receptor reveals molecular determinants of selective ligand recognitionMattia Deluigi, Lena Morstein, Matthias Schuster, et al.
Science Advances|May 24, 2023
Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant EnterobacteriaceaeMatthias Schuster, Emile Brabet, Kathryn K Oi, et al.
Pageof 3